Heart Failure Self-care With the Aid of a Smartphone Application Read more about Heart Failure Self-care With the Aid of a Smartphone Application
To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer Read more about To Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
Colesevelam for Children With Type 2 Diabetes Read more about Colesevelam for Children With Type 2 Diabetes
Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine Read more about Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma Read more about Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication Read more about A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome Read more about An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer Read more about EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus Read more about A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C Read more about Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C